Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

Further, AXS-05 reduced worsening for overall Alzheimer’s disease severity compared to placebo, as assessed by the Clinical Global Impression of Severity (CGI-S) for Alzheimer’s disease (p<0.001).

Posdinemab is an investigational monoclonal antibody that targets the mid-domain of Alzheimer's disease-specific ...

MONDAY, Jan. 6, 2025 (HealthDay News) -- In a clinical practice guideline issued by the Alzheimer's Association and published ...

A new guideline published in Alzheimer’s & Dementia ... become sufficiently validated for appropriate clinical use in real-world practice,” Alireza Atri, MD, PhD, chief medical officer ...

The Alzheimer’s Association ... “Some details of the guideline will likely require modification as new tools and biomarkers become sufficiently validated for appropriate clinical use in ...

WATERLOO − Cedar Valley Clinical Research in Waterloo is seeking participants for a clinical study of an investigational medication for early Alzheimer’s disease. This study is for patients ...

A three-step process underscores new clinical practice guidelines for primary and specialty care clinicians to evaluate ...